The range of infectious diseases that cause distress, illness and death remains truly staggering. Malaria, pneumonia, HIV, meningitis, plague, yellow fever, cholera, influenza and most recently Ebola continue to influence not only individuals but the economic and social life within large regions of the world. Most countries have experienced epidemics of one form or another over the past decade. The majority has been contained, but the H1N1 influenza outbreak of 2009 briefly demonstrated the potential for global reach.
Strong arguments support cancer screening in a clinical setting, but for insurers offering Critical Illness (CI) policies it could mean they receive claims for tiny tumors that are anything but serious. Affordable access to sensitive imaging technology has the potential to drive a massive rise in the numbers of insignificant cancers being detected.